24/7 Market News – (NASDAQ: TTNP)  Titan Pharmaceuticals, Inc. Shares are Moving this Morning, up More than 15% on Increasing Volume on News of FDA Clearance.

July 5, 2022

The stock has more than 1800 trades and is currently trading at .62 The company’s highest trading volume day this year was less than 10 million, with a 52-week high of $2.50.

[mstock id=”73007″ asset=”ttnp”]

https://www.prnewswire.com/news-releases/titan-pharmaceuticals-announces-fda-clearance-of-ind-application-for-nalmefene-implant-301580339.html

Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

SOUTH SAN FRANCISCO, Calif., July 5, 2022 /PRNewswire/ — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that the U.S. Food and Drug Administration (“FDA”) has cleared its Investigational New Drug (“IND”) application for a Phase 1 study of its six-month or longer subdermal formulation of nalmefene, an opioid antagonist, intended for the prevention of relapse following opioid detoxification in adults with Opioid Use Disorder (“OUD”).

Pages: 1 2

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.